<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p647.xml</sm:loc>
    <ifp:title>Reflecting the Debates of Updating the Prostate Cancer Guidelines</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p650.xml</sm:loc>
    <ifp:title>Prostate Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p685.xml</sm:loc>
    <ifp:title>Point: Open Radical Prostatectomy Should Not Be Abandoned</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p689.xml</sm:loc>
    <ifp:title>Counterpoint: Robot-Assisted Laparoscopic Prostatectomy: Perhaps the Surgical Gold Standard for Prostate Cancer Care</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p693.xml</sm:loc>
    <ifp:title>Point: Active Surveillance for Favorable Risk Prostate Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p699.xml</sm:loc>
    <ifp:title>Counterpoint: The Case for Immediate Active Treatment</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p703.xml</sm:loc>
    <ifp:title>Point: TheValue of Predicting Life Expectancy in Men with Clinically Localized Prostate Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p709.xml</sm:loc>
    <ifp:title>Counterpoint: Prostate Cancer Life Expectancy Can Not Be Accurately Predicted From Currently Available Tools</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p714.xml</sm:loc>
    <ifp:title>Prostate Cancer Early Detection</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/5/7/article-p737.xml</sm:loc>
    <ifp:title>Update on PSA Testing</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
